In terms of this, traditional hypercholesterolemia target PCSK9 inhibition also shows the ability to enhance anti-PD-1 effect and CD8+ T cells activity in tumor, as well as suppressing the MDSCs infiltration [157, 158]. This evidence concerns the gene CD8A and neoplasm.